EMJ Gastroenterology 11 [Supplement 3] . 2022

In this issue

The production of TNFα during chronic inflammation leads to organ damage due to excessive inflammation. As the first in a series of articles exploring the value of tumour necrosis factor inhibitors (anti-TNFs) in treating immune-mediated disease, this review delved into the use of these therapies for inflammatory conditions, analysing their associated safety in pregnancy.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given